The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Joint Pain Injections Market Research Report 2025
Synopsis
Based on injection type, the global joint pain injections market has been segmented into corticosteroid injections, hyaluronic acid injections, and others. In terms of joint type, the global joint pain injections market has been divided into knee & ankle, hip joint, shoulder & elbow, facet joints of the spine, and others. Based on distribution channel, the market has been segregated into hospital pharmacies, retail pharmacies, and online pharmacies.
The global Joint Pain Injections market was valued at US$ 2768.5 million in 2023 and is anticipated to reach US$ 4013.6 million by 2030, witnessing a CAGR of 5.0% during the forecast period 2024-2030.
North American market for Joint Pain Injections is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Joint Pain Injections is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Joint Pain Injections include Allergan, Pfizer, Sanofi, Anika Therapeutics, Ferring, Bioventus, Flexion Therapeutics, Zimmer Biomet Holdings and SEIKAGAKU CORPORATION, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Joint Pain Injections, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Joint Pain Injections.
Report Scope
The Joint Pain Injections market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Joint Pain Injections market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Joint Pain Injections manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Allergan
Pfizer
Sanofi
Anika Therapeutics
Ferring
Bioventus
Flexion Therapeutics
Zimmer Biomet Holdings
SEIKAGAKU CORPORATION
Chugai Pharmaceutical
Segment by Type
Corticosteroid Injections
Hyaluronic Acid Injections
Others
Segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Joint Pain Injections manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Joint Pain Injections in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Based on injection type, the global joint pain injections market has been segmented into corticosteroid injections, hyaluronic acid injections, and others. In terms of joint type, the global joint pain injections market has been divided into knee & ankle, hip joint, shoulder & elbow, facet joints of the spine, and others. Based on distribution channel, the market has been segregated into hospital pharmacies, retail pharmacies, and online pharmacies.
The global Joint Pain Injections market was valued at US$ 2768.5 million in 2023 and is anticipated to reach US$ 4013.6 million by 2030, witnessing a CAGR of 5.0% during the forecast period 2024-2030.
North American market for Joint Pain Injections is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Joint Pain Injections is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Joint Pain Injections include Allergan, Pfizer, Sanofi, Anika Therapeutics, Ferring, Bioventus, Flexion Therapeutics, Zimmer Biomet Holdings and SEIKAGAKU CORPORATION, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Joint Pain Injections, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Joint Pain Injections.
Report Scope
The Joint Pain Injections market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Joint Pain Injections market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Joint Pain Injections manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Allergan
Pfizer
Sanofi
Anika Therapeutics
Ferring
Bioventus
Flexion Therapeutics
Zimmer Biomet Holdings
SEIKAGAKU CORPORATION
Chugai Pharmaceutical
Segment by Type
Corticosteroid Injections
Hyaluronic Acid Injections
Others
Segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Joint Pain Injections manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Joint Pain Injections in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Joint Pain Injections Market Overview
1.1 Product Overview and Scope of Joint Pain Injections
1.2 Joint Pain Injections Segment by Type
1.2.1 Global Joint Pain Injections Market Value Comparison by Type (2024-2030)
1.2.2 Corticosteroid Injections
1.2.3 Hyaluronic Acid Injections
1.2.4 Others
1.3 Joint Pain Injections Segment by Application
1.3.1 Global Joint Pain Injections Market Value by Application: (2024-2030)
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Global Joint Pain Injections Market Size Estimates and Forecasts
1.4.1 Global Joint Pain Injections Revenue 2019-2030
1.4.2 Global Joint Pain Injections Sales 2019-2030
1.4.3 Global Joint Pain Injections Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Joint Pain Injections Market Competition by Manufacturers
2.1 Global Joint Pain Injections Sales Market Share by Manufacturers (2019-2024)
2.2 Global Joint Pain Injections Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Joint Pain Injections Average Price by Manufacturers (2019-2024)
2.4 Global Joint Pain Injections Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Joint Pain Injections, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Joint Pain Injections, Product Type & Application
2.7 Joint Pain Injections Market Competitive Situation and Trends
2.7.1 Joint Pain Injections Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Joint Pain Injections Players Market Share by Revenue
2.7.3 Global Joint Pain Injections Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Joint Pain Injections Retrospective Market Scenario by Region
3.1 Global Joint Pain Injections Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Joint Pain Injections Global Joint Pain Injections Sales by Region: 2019-2030
3.2.1 Global Joint Pain Injections Sales by Region: 2019-2024
3.2.2 Global Joint Pain Injections Sales by Region: 2025-2030
3.3 Global Joint Pain Injections Global Joint Pain Injections Revenue by Region: 2019-2030
3.3.1 Global Joint Pain Injections Revenue by Region: 2019-2024
3.3.2 Global Joint Pain Injections Revenue by Region: 2025-2030
3.4 North America Joint Pain Injections Market Facts & Figures by Country
3.4.1 North America Joint Pain Injections Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Joint Pain Injections Sales by Country (2019-2030)
3.4.3 North America Joint Pain Injections Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Joint Pain Injections Market Facts & Figures by Country
3.5.1 Europe Joint Pain Injections Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Joint Pain Injections Sales by Country (2019-2030)
3.5.3 Europe Joint Pain Injections Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Joint Pain Injections Market Facts & Figures by Country
3.6.1 Asia Pacific Joint Pain Injections Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Joint Pain Injections Sales by Country (2019-2030)
3.6.3 Asia Pacific Joint Pain Injections Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Joint Pain Injections Market Facts & Figures by Country
3.7.1 Latin America Joint Pain Injections Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Joint Pain Injections Sales by Country (2019-2030)
3.7.3 Latin America Joint Pain Injections Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Joint Pain Injections Market Facts & Figures by Country
3.8.1 Middle East and Africa Joint Pain Injections Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Joint Pain Injections Sales by Country (2019-2030)
3.8.3 Middle East and Africa Joint Pain Injections Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Joint Pain Injections Sales by Type (2019-2030)
4.1.1 Global Joint Pain Injections Sales by Type (2019-2024)
4.1.2 Global Joint Pain Injections Sales by Type (2025-2030)
4.1.3 Global Joint Pain Injections Sales Market Share by Type (2019-2030)
4.2 Global Joint Pain Injections Revenue by Type (2019-2030)
4.2.1 Global Joint Pain Injections Revenue by Type (2019-2024)
4.2.2 Global Joint Pain Injections Revenue by Type (2025-2030)
4.2.3 Global Joint Pain Injections Revenue Market Share by Type (2019-2030)
4.3 Global Joint Pain Injections Price by Type (2019-2030)
5 Segment by Application
5.1 Global Joint Pain Injections Sales by Application (2019-2030)
5.1.1 Global Joint Pain Injections Sales by Application (2019-2024)
5.1.2 Global Joint Pain Injections Sales by Application (2025-2030)
5.1.3 Global Joint Pain Injections Sales Market Share by Application (2019-2030)
5.2 Global Joint Pain Injections Revenue by Application (2019-2030)
5.2.1 Global Joint Pain Injections Revenue by Application (2019-2024)
5.2.2 Global Joint Pain Injections Revenue by Application (2025-2030)
5.2.3 Global Joint Pain Injections Revenue Market Share by Application (2019-2030)
5.3 Global Joint Pain Injections Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Allergan
6.1.1 Allergan Corporation Information
6.1.2 Allergan Description and Business Overview
6.1.3 Allergan Joint Pain Injections Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Allergan Joint Pain Injections Product Portfolio
6.1.5 Allergan Recent Developments/Updates
6.2 Pfizer
6.2.1 Pfizer Corporation Information
6.2.2 Pfizer Description and Business Overview
6.2.3 Pfizer Joint Pain Injections Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Pfizer Joint Pain Injections Product Portfolio
6.2.5 Pfizer Recent Developments/Updates
6.3 Sanofi
6.3.1 Sanofi Corporation Information
6.3.2 Sanofi Description and Business Overview
6.3.3 Sanofi Joint Pain Injections Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Sanofi Joint Pain Injections Product Portfolio
6.3.5 Sanofi Recent Developments/Updates
6.4 Anika Therapeutics
6.4.1 Anika Therapeutics Corporation Information
6.4.2 Anika Therapeutics Description and Business Overview
6.4.3 Anika Therapeutics Joint Pain Injections Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Anika Therapeutics Joint Pain Injections Product Portfolio
6.4.5 Anika Therapeutics Recent Developments/Updates
6.5 Ferring
6.5.1 Ferring Corporation Information
6.5.2 Ferring Description and Business Overview
6.5.3 Ferring Joint Pain Injections Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Ferring Joint Pain Injections Product Portfolio
6.5.5 Ferring Recent Developments/Updates
6.6 Bioventus
6.6.1 Bioventus Corporation Information
6.6.2 Bioventus Description and Business Overview
6.6.3 Bioventus Joint Pain Injections Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Bioventus Joint Pain Injections Product Portfolio
6.6.5 Bioventus Recent Developments/Updates
6.7 Flexion Therapeutics
6.6.1 Flexion Therapeutics Corporation Information
6.6.2 Flexion Therapeutics Description and Business Overview
6.6.3 Flexion Therapeutics Joint Pain Injections Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Flexion Therapeutics Joint Pain Injections Product Portfolio
6.7.5 Flexion Therapeutics Recent Developments/Updates
6.8 Zimmer Biomet Holdings
6.8.1 Zimmer Biomet Holdings Corporation Information
6.8.2 Zimmer Biomet Holdings Description and Business Overview
6.8.3 Zimmer Biomet Holdings Joint Pain Injections Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Zimmer Biomet Holdings Joint Pain Injections Product Portfolio
6.8.5 Zimmer Biomet Holdings Recent Developments/Updates
6.9 SEIKAGAKU CORPORATION
6.9.1 SEIKAGAKU CORPORATION Corporation Information
6.9.2 SEIKAGAKU CORPORATION Description and Business Overview
6.9.3 SEIKAGAKU CORPORATION Joint Pain Injections Sales, Revenue and Gross Margin (2019-2024)
6.9.4 SEIKAGAKU CORPORATION Joint Pain Injections Product Portfolio
6.9.5 SEIKAGAKU CORPORATION Recent Developments/Updates
6.10 Chugai Pharmaceutical
6.10.1 Chugai Pharmaceutical Corporation Information
6.10.2 Chugai Pharmaceutical Description and Business Overview
6.10.3 Chugai Pharmaceutical Joint Pain Injections Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Chugai Pharmaceutical Joint Pain Injections Product Portfolio
6.10.5 Chugai Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Joint Pain Injections Industry Chain Analysis
7.2 Joint Pain Injections Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Joint Pain Injections Production Mode & Process
7.4 Joint Pain Injections Sales and Marketing
7.4.1 Joint Pain Injections Sales Channels
7.4.2 Joint Pain Injections Distributors
7.5 Joint Pain Injections Customers
8 Joint Pain Injections Market Dynamics
8.1 Joint Pain Injections Industry Trends
8.2 Joint Pain Injections Market Drivers
8.3 Joint Pain Injections Market Challenges
8.4 Joint Pain Injections Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
